Cost‐effective endoscopic screening for gastric cancer in a cohort with low Helicobacter pylori prevalence
Journal of Gastroenterology and Hepatology · 2024-11 · 39 (11) · 2424-2431
DOI: 10.1111/jgh.16715 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 09.08.2024. Verfasst von Fumiaki Ishibashi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, International University of Health and Welfare Ichikawa Hospital, Ichikawa, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms, Cost-Benefit Analysis, Helicobacter Infections, Helicobacter pylori. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Background and Aim Periodic endoscopic screening for gastric cancer (GC) is widely performed in East Asia; however, the optimal screening strategy remains unclear. This study aimed to determine the most cost‐effective endoscopic screening strategy for the detection and treatment of GC in a cohort with a low Helicobacter pylori prevalence.
Methods
The following data were retrospectively extracted from participants who received screening endoscopy between April 2019 and March 2023: age, H. pylori infection status, presence of intestinal metaplasia, pathological diagnosis of GC, and the interval between the most recent endoscopies. A Markov state transition model was constructed based on the cohort data. The cost‐effectiveness of 15 strategies with different starting ages (40/50/60 years) and screening intervals (1/2/3/4/5 years) was compared. The net monetary benefit (NMB) and incremental cost‐effectiveness ratio (ICER) of quality‐adjusted life‐years gained by treatment were used as outcomes.
Results
A simulation model was constructed based on the cohort data of 94 137 participants (mean age 54.5 years, males 57.9%; 74.4% H. pylori ‐naïve, 94.2% intestinal metaplasia‐negative). The results of the base‐case analysis showed that the screening strategy of 4‐year intervals starting at the age of 40 years had the highest NMB (97 401 578 yen). In both the Monte Carlo simulation and one‐way sensitivity analysis with a varying probability of H. pylori infection status transition, the ICER was superior in the screening strategy every 4 years, starting at age 40 years.
Conclusions
Our simulation showed that endoscopic screening at 4‐year intervals starting at the age of 40 years was the most cost‐effective method.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, International University of Health and Welfare Ichikawa Hospital, Ichikawa, Japan.
- Endoscopy Center, Koganei Tsurukame Clinic, Tokyo, Japan.
- Digestive Disease Center, Shinjuku Tsurukame Clinic, Tokyo, Japan.
- Research and Development Initiative, Chuo University, Tokyo, Japan.
ORCID-Profile: Fumiaki Ishibashi, Sho Suzuki
Zitieren
APA
Ishibashi, F., Suzuki, S., Kobayashi, K., Tanaka, R., Kawakami, T., Mochida, K., Nagai, M., Ishibashi, Y., & Morishita, T. (2024). Cost‐effective endoscopic screening for gastric cancer in a cohort with low Helicobacter pylori prevalence. Journal of Gastroenterology and Hepatology, 39(11), 2424-2431. https://doi.org/10.1111/jgh.16715
Vancouver
Ishibashi F, Suzuki S, Kobayashi K, Tanaka R, Kawakami T, Mochida K, et al. Cost‐effective endoscopic screening for gastric cancer in a cohort with low Helicobacter pylori prevalence. Journal of Gastroenterology and Hepatology. 2024;39(11):2424-2431. doi:10.1111/jgh.16715
BibTeX
@article{Ishibashi2024,
author = {Ishibashi, Fumiaki and Suzuki, Sho and Kobayashi, Konomi and Tanaka, Ryu and Kawakami, Tomohiro and Mochida, Kentaro and Nagai, Mizuki and Ishibashi, Yuichi and Morishita, Tetsuo},
title = {Cost‐effective endoscopic screening for gastric cancer in a cohort with low Helicobacter pylori prevalence},
journal = {Journal of Gastroenterology and Hepatology},
year = {2024},
volume = {39},
number = {11},
pages = {2424--2431},
doi = {10.1111/jgh.16715}
}
EUVIMED